Dr. Himanshu Srivastava Clinical Oncologist in Jalandhar

Dr. Himanshu Srivastava
Clinical Oncologist, Jalandhar

MBBS, DMRT, DNB, PDCR

  • Dr.Himanshu Srivastava is Consultant at Capitol Hospital Jalandhar. 
  • He has an experience of 10 years in the field of Clinical Oncology and Radiation Oncology . 
  • He has expertise in management of all types of solid tumours with Radiotherapy and Chemotherapy. 
  • He is well versed with modern radiotherapy techniques, and his specialties are IMRT, IGRT, Rapid-Arc, SBRT, SRS/SRT, Brachytherapy etc. 
  • He has published many research papers in leading Journals in Oncology.
  • Languages :English, Hindi

Experience

Registrar, Apollo Hospital Delhi, New Delhi June, 2010 -  Present

Attending Consultant, Rajiv Gandhi Cancer Institute & Research Centre, New Delhi June, 2012 -  Present

Consultant, Capitol Hospital, Jalandhar June, 2016 -  Present

Specialities

  • Clinical Oncology

  • Cancer Chemotherapy

  • Cancer Radiation Therapy

  • Gyneac Oncology

  • Head and Neck Surgical Oncology

  • Neuro Oncology

  • Uro Oncology

Procedures

  • Radiation Therapy

Expertise


Education

Practice Information

Capitol Hospital, Jalandhar

Capitol Hospital, Jalandhar

Jalandhar-Pathankot Road, Near Reru Chowk, NH-44, Jalandhar, Punjab - 144012

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Himanshu Srivastava and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Adjuvant radiation therapy and temozolomide in gliosarcoma – is it enough? Case series of 7 patients . Srivastava H, Dewan A, Sharma SK, Negi P, Dewan DK, Pasricha S, Mehrotra K Asian Journal of Neurosurgery. 
  • Management of lung cancer brain metastasis-an overview Srivastava H, Negi P, Kingsley PA, Sachdeva J. Asian Journal of Oncology.
  • Male breast cancer: an 8-year experience in a single tertiary oncology center in India. Srivastava H, Sharma SK, Dewan A, Negi P, Ahlawat P.  International Journal of Medical Paediatrics and Oncology 2016; 2(3): 96-101
  • Weekly versus three-weekly cisplatin-based concurrent chemoradiotherapy as definitive treatment in head and neck cancer- where do we stand? Rawat S, Srivastava H, Ahlawat P, Pal M, Gupta G, Chauhan D, Tandon S, Khurana R GJO 2016; 21: 6-11
  • Persistent post-radiotherapy pain and locoregional recurrence in head and neck cancer-Is there a hidden link? Srivastava P, Kingsley PA, Srivastava H, Sachdeva J, Kaur PKorean J Pain 2015 Apr; 28 (2): 116-121.
  • Review article: Three weekly versus weekly cisplatin as radiosensitizer in head and neck cancer: A decision dilemma.Negi P, Kingsley PA, Srivastava H, Sharma SK Asian Pac J Cancer Prev 2016; 17 (4): 1617-1623. 
  • Radiation therapy – an effective tool for analgesia in metastatic bone disease in breast cancer. Negi P, Kingsley PA, Sachdeva J, Srivastava H.  J Evolution Med Dent Sci 2017; 6(61): 4450-4453.
  • Dr. Neal Joseph Fellowship in 2010 awarded at Association of Radiation Oncologist India Conference, Hyderabad
  • Best Doctor Award in 2015 at Foundation Day Celebration, Rajiv Gandhi Cancer Institute & Research Centre, New Delhi
  • Member of Association of Radiation Oncologist of India